Table 1.

Titration of Vectors on Different Cell Lines Before and After Factor Xa Cleavage

Kit-Negative CellsKit-Positive Cells (%)
NIH 3T3 A431HMC-1TF-1
−Xa +Xa−Xa +Xa −Xa +Xa −Xa +Xa
SCFXA 3.6 × 105 5 × 105 4.2 × 105 6.7 × 105 4.2 40  2  38  
EXA  5 × 105 5 × 105 2 × 102 1 × 106 40  36  45  46  
4070A 5.4 × 105 5 × 105 2.5 × 106 2.6 × 106 63 64  77  75 
Kit-Negative CellsKit-Positive Cells (%)
NIH 3T3 A431HMC-1TF-1
−Xa +Xa−Xa +Xa −Xa +Xa −Xa +Xa
SCFXA 3.6 × 105 5 × 105 4.2 × 105 6.7 × 105 4.2 40  2  38  
EXA  5 × 105 5 × 105 2 × 102 1 × 106 40  36  45  46  
4070A 5.4 × 105 5 × 105 2.5 × 106 2.6 × 106 63 64  77  75 

The host-range properties of the amphotropic vectors incorporating the chimeric envelope SCFXA were tested on Kit-expressing and nonexpressing cell lines with EXA and wild-type 4070A vectors as controls. All of these vectors were also tested after treatment with 4 μg/mL factor Xa protease before infection. The titer of SCFXA was reduced considerably compared with that of EXA and 4070A on the Kit-positive cell lines, but was restored by factor Xa protease cleavage. The titer of SCFXA was unaffected by factor Xa cleavage on the Kit-negative cell lines. These data show that infectivity of the SCFA vector on Kit-positive cells is blocked by the display of SCF and can be restored by cleavage of the displayed domain. Titers are shown as enzyme-forming units per mL (adherent cells) or percentage blue cells (suspension cells).

or Create an Account

Close Modal
Close Modal